Molecular Methods Market by Product Type, Technology, Automation Level, Detection Chemistry, Application, End User

The Molecular Methods Market is projected to reach USD 2.79 Billion in 2026. It is expected to continue growing at a CAGR of 7.20%, reaching USD 4.22 Billion by 2032.

Molecular methods are reshaping clinical diagnostics, life sciences research, public health surveillance, agriculture, forensics, and biopharmaceutical development. Core technologies such as PCR, qPCR, RT-PCR, digital PCR, next-generation sequencing, Sanger sequencing, in situ hybridization, microarrays, and CRISPR-based assays enable sensitive detection of DNA and RNA targets with high analytical specificity.

Demand is supported by precision medicine, oncology biomarker testing, antimicrobial resistance monitoring, inherited disease screening, transplant diagnostics, food safety testing, and rapid infectious disease detection. Verified adoption accelerated during COVID-19, when the WHO, CDC, and national laboratories relied on nucleic acid amplification testing as a reference approach for SARS-CoV-2 detection. The landscape is now moving beyond emergency testing toward routine, automated, decentralized, and data-connected molecular workflows.

Transformative Shifts in the Molecular Methods Landscape

The molecular methods landscape is shifting from single-target, laboratory-centered testing toward multiplex, high-throughput, and sample-to-answer platforms. Laboratories are adopting syndromic panels, liquid biopsy assays, companion diagnostics, pharmacogenomic panels, and metagenomic sequencing to generate clinically actionable results faster and with broader biological context.

A second shift is the convergence of molecular diagnostics with automation, cloud informatics, and quality-by-design manufacturing. The National Human Genome Research Institute has documented the steep decline in sequencing costs since the Human Genome Project, enabling broader use of genomic analysis. At the same time, regulators are emphasizing analytical validation, traceability, cybersecurity, and post-market performance, making compliance and data integrity central to competitive differentiation.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the molecular methods value chain. In assay development, AI supports primer and probe design, off-target prediction, target prioritization, and synthetic control optimization. In testing operations, machine learning improves quality control, contamination flagging, run monitoring, variant calling, copy-number interpretation, and workflow scheduling.

The impact is most powerful when AI is paired with validated molecular data, laboratory information systems, and clinical decision support. AI can shorten development cycles and improve interpretation consistency, but industry leaders must manage bias, explainability, regulatory documentation, data privacy, and cybersecurity. The winning model is not autonomous replacement of molecular expertise, but evidence-based augmentation of scientists, pathologists, and laboratory professionals.

Key Regional Insights for Molecular Methods

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN economies invest in genomics, infectious disease surveillance, oncology testing, reproductive health, and domestic molecular diagnostics manufacturing. National sequencing initiatives, tuberculosis and antimicrobial resistance programs, and increasing hospital laboratory automation support broader use of PCR, qPCR, digital PCR, and next-generation sequencing across the region. North America remains a benchmark for molecular innovation because of strong academic research, FDA-regulated diagnostics, CLIA laboratory infrastructure, public health genomics, venture-backed technology development, and established adoption of companion diagnostics and sequencing-based oncology testing.

Europe benefits from sophisticated healthcare systems, cross-border research networks, national genomic medicine programs, and the European Union regulatory framework for in vitro diagnostics, which is increasing emphasis on clinical evidence, quality systems, and post-market surveillance. Latin America shows rising demand for molecular infectious disease testing, oncology diagnostics, blood screening, and reference laboratory expansion, led by countries strengthening surveillance for respiratory viruses, arboviruses, tuberculosis, and antimicrobial resistance. The Middle East is investing in national genomics programs, precision medicine, newborn screening, and advanced hospital systems, particularly across Gulf economies. Africa is prioritizing molecular capacity for tuberculosis, HIV, malaria, antimicrobial resistance, Ebola, mpox, and outbreak surveillance, supported by public health partnerships, genomic epidemiology networks, and expanding regional laboratory infrastructure.

Key Group Insights Across Strategic Blocs

ASEAN markets are strengthening molecular testing capacity through hospital modernization, cross-border disease surveillance, tuberculosis control, food safety testing, and growing private laboratory networks. The GCC is advancing precision medicine and genomics through national health transformation programs, specialized cancer centers, newborn screening, and high-value hospital procurement. The European Union is shaped by harmonized regulatory expectations under the in vitro diagnostic regulatory framework, cross-country research collaboration, data protection requirements, and strong demand for validated clinical evidence.

BRICS economies combine large patient populations with rising domestic manufacturing, public health testing needs, infectious disease monitoring, oncology diagnostics, and strong demand for cost-efficient molecular platforms. G7 countries lead in research funding, reimbursement maturity, regulatory science, biobank infrastructure, genomic medicine implementation, and commercialization of advanced molecular diagnostics. NATO members increasingly view molecular methods as part of biosecurity readiness, pathogen surveillance, military medicine, biodefense research, and resilient healthcare supply chains, reinforcing the strategic value of rapid molecular detection and genomic sequencing.

Key Country Insights for Molecular Methods

The United States leads in molecular innovation through biotechnology clusters, FDA-regulated diagnostics, large reference laboratories, national public health sequencing capacity, and broad use of oncology, reproductive health, pharmacogenomic, and infectious disease assays. Canada emphasizes public health laboratories, genomics research, cancer testing, and equitable testing access, while Mexico and Brazil are expanding molecular capacity for infectious disease surveillance, oncology diagnostics, blood screening, and private diagnostic services. The United Kingdom, Germany, France, Italy, and Spain support strong clinical research ecosystems, advanced hospital laboratories, national or regional genomic medicine programs, and increasing adoption of sequencing, companion diagnostics, and molecular pathology.

Russia maintains demand across infectious disease testing, epidemiology, and research applications, while China is scaling sequencing, molecular oncology, reproductive health testing, pathogen surveillance, and domestic instrument and reagent production. India is expanding molecular diagnostics through tuberculosis programs, infectious disease testing, private laboratory networks, genomic research, and oncology adoption. Japan, South Korea, and Australia are advanced molecular methods markets with strong quality standards, cancer diagnostics uptake, newborn and inherited disease testing, public health surveillance capabilities, and mature adoption of automated laboratory workflows.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that combine analytical sensitivity, multiplexing, automation, contamination control, and interoperability with laboratory information systems. Product strategies should align with validated clinical utility, reimbursement pathways, regulatory requirements, cybersecurity expectations, and total cost of ownership rather than instrument performance alone.

Organizations should invest in scalable sample preparation, quality management, secure data pipelines, AI-assisted interpretation, and evidence generation across diverse populations. Partnerships with hospitals, public health agencies, reference laboratories, biopharma organizations, and academic genomics centers can accelerate adoption. Regional strategies must balance premium innovation in mature healthcare systems with robust, affordable, and easy-to-maintain systems for high-growth and resource-constrained settings.

Research Methodology for Molecular Methods Insights

This executive summary is built from a structured secondary research approach using publicly available, verifiable sources, including regulatory agencies, public health organizations, national genomics initiatives, peer-reviewed scientific literature, healthcare policy references, laboratory standards, and disease surveillance guidance. Core evidence areas include molecular diagnostics adoption, sequencing cost trends, regulatory developments, infectious disease testing guidance, genomic medicine implementation, antimicrobial resistance monitoring, and precision oncology practices.

The analysis applies triangulation across technology trends, regional healthcare infrastructure, laboratory adoption patterns, regulatory requirements, and end-user demand. Insights are evaluated for relevance to PCR, qPCR, RT-PCR, digital PCR, next-generation sequencing, Sanger sequencing, companion diagnostics, syndromic testing, molecular pathology, and genomic surveillance. Emphasis is placed on data-backed developments and operational implications rather than speculative market claims.

Conclusion: Molecular Methods as a Precision Health Foundation

Molecular methods have moved from specialized research tools to essential infrastructure for modern healthcare, public health, biosecurity, agriculture, and life sciences innovation. Their value lies in the ability to detect, quantify, and characterize genetic material with speed, specificity, sensitivity, and clinical relevance.

Future competitiveness will depend on validated assays, automated workflows, AI-enabled interpretation, regulatory readiness, quality systems, secure data governance, and regionally adapted commercialization. Organizations that combine scientific rigor with scalable operations and trusted molecular data practices will be best positioned to support demand across diagnostics, therapeutics, surveillance, and precision medicine.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Molecular Methods Market, by Product Type

7.1. Instruments
7.1.1. Benchtop Instruments
7.1.2. High Throughput Instruments
7.2. Reagents
7.2.1. Consumables
7.2.2. Kits
7.3. Services
7.3.1. Analytical Services
7.3.2. Testing Services
7.4. Software
7.4.1. Bioinformatics Software
7.4.2. Data Management Software

8. Molecular Methods Market, by Technology

8.1. Gene Editing
8.1.1. CRISPR
8.1.2. TALEN
8.2. Microarrays
8.2.1. Expression Microarrays
8.2.2. Genotyping Microarrays
8.3. PCR
8.3.1. Conventional PCR
8.3.2. Digital PCR
8.3.3. Real-Time PCR
8.4. Sequencing
8.4.1. Next Generation Sequencing
8.4.2. Sanger Sequencing
8.4.3. Third Generation Sequencing

9. Molecular Methods Market, by Automation Level

9.1. Fully Automated Systems
9.2. Semi-Automated Systems
9.3. Manual Methods

10. Molecular Methods Market, by Detection Chemistry

10.1. Fluorescence-Based
10.2. Chemiluminescence
10.3. Colorimetric
10.4. Electrochemical

11. Molecular Methods Market, by Application

11.1. Clinical Diagnostics
11.1.1. Infectious Disease Testing
11.1.2. Oncology Testing
11.1.3. Genetic Testing
11.1.4. Pharmacogenomics
11.2. Environmental Testing
11.3. Forensic & Legal Testing
11.4. Research & Development
11.5. Food & Agriculture Testing

12. Molecular Methods Market, by End User

12.1. Academic And Research Institutes
12.2. Biotechnology Companies
12.3. Contract Research Organizations
12.4. Hospitals And Clinics
12.5. Pharmaceutical Companies

13. Asia-Pacific Molecular Methods Market
14. North America Molecular Methods Market
15. Latin America Molecular Methods Market
16. Europe Molecular Methods Market
17. Middle East Molecular Methods Market
18. Africa Molecular Methods Market
19. ASEAN Molecular Methods Market
20. GCC Molecular Methods Market
21. European Union Molecular Methods Market
22. BRICS Molecular Methods Market
23. G7 Molecular Methods Market
24. NATO Molecular Methods Market
25. United States Molecular Methods Market
26. Canada Molecular Methods Market
27. Mexico Molecular Methods Market
28. Brazil Molecular Methods Market
29. United Kingdom Molecular Methods Market
30. Germany Molecular Methods Market
31. France Molecular Methods Market
32. Russia Molecular Methods Market
33. Italy Molecular Methods Market
34. Spain Molecular Methods Market
35. China Molecular Methods Market
36. India Molecular Methods Market
37. Japan Molecular Methods Market
38. Australia Molecular Methods Market
39. South Korea Molecular Methods Market

40. Competitive Landscape

40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025

41. Company Profiles

41.1. Abbott Laboratories
41.2. Agilent Technologies Inc.
41.3. Becton Dickinson and Company
41.4. Bio-Rad Laboratories Inc
41.5. bioMérieux SA
41.6. Danaher Corporation
41.7. DiaSorin S.p.A
41.8. Eurofins Scientific SE
41.9. Exact Sciences Corporation
41.10. F. Hoffmann-La Roche Ltd.
41.11. GenScript Biotech Corporation
41.12. Guardant Health Inc
41.13. Hologic Inc.
41.14. Illumina Inc.
41.15. Lonza Group AG
41.16. Merck KGaA
41.17. Molbio Diagnostics Private Limited
41.18. Myriad Genetics Inc
41.19. Natera Inc
41.20. NeoGenomics Laboratories Inc.
41.21. QIAGEN N.V
41.22. Revvity Inc
41.23. Sartorius AG
41.24. Seegene Inc.
41.25. SGS SA
41.26. Sysmex Corporation
41.27. Thermo Fisher Scientific Inc.

List of Figures

FIGURE 1. GLOBAL MOLECULAR METHODS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MOLECULAR METHODS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MOLECULAR METHODS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MOLECULAR METHODS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL MOLECULAR METHODS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL MOLECULAR METHODS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO MOLECULAR METHODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL MOLECULAR METHODS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BENCHTOP INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BENCHTOP INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BENCHTOP INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HIGH THROUGHPUT INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HIGH THROUGHPUT INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HIGH THROUGHPUT INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANALYTICAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANALYTICAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANALYTICAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOINFORMATICS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOINFORMATICS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOINFORMATICS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENE EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CRISPR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CRISPR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CRISPR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TALEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TALEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TALEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MICROARRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MICROARRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MICROARRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL EXPRESSION MICROARRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL EXPRESSION MICROARRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL EXPRESSION MICROARRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENOTYPING MICROARRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENOTYPING MICROARRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENOTYPING MICROARRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL THIRD GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL THIRD GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL THIRD GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MANUAL METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MANUAL METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MANUAL METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL FLUORESCENCE-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL FLUORESCENCE-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL FLUORESCENCE-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CHEMILUMINESCENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CHEMILUMINESCENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CHEMILUMINESCENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ONCOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ONCOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL FORENSIC & LEGAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL FORENSIC & LEGAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL FORENSIC & LEGAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL FOOD & AGRICULTURE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL FOOD & AGRICULTURE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL FOOD & AGRICULTURE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 179. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. EUROPE MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 204. EUROPE MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. EUROPE MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 206. EUROPE MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 207. EUROPE MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 208. EUROPE MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 209. EUROPE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. EUROPE MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 211. EUROPE MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 212. EUROPE MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 213. EUROPE MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 214. EUROPE MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 215. EUROPE MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 216. EUROPE MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. EUROPE MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 218. EUROPE MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. AFRICA MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 236. AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. AFRICA MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 238. AFRICA MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 239. AFRICA MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 240. AFRICA MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 241. AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. AFRICA MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 243. AFRICA MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 244. AFRICA MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 245. AFRICA MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 246. AFRICA MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 247. AFRICA MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 248. AFRICA MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. AFRICA MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 250. AFRICA MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. ASEAN MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 252. ASEAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 253. ASEAN MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 254. ASEAN MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 255. ASEAN MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 256. ASEAN MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 257. ASEAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. ASEAN MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 259. ASEAN MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 260. ASEAN MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 261. ASEAN MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 262. ASEAN MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 263. ASEAN MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 264. ASEAN MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. ASEAN MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 266. ASEAN MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GCC MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 268. GCC MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 269. GCC MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 270. GCC MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 271. GCC MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 272. GCC MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 273. GCC MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 274. GCC MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 275. GCC MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 276. GCC MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 277. GCC MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 278. GCC MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 279. GCC MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 280. GCC MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 281. GCC MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 282. GCC MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. BRICS MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 300. BRICS MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 301. BRICS MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 302. BRICS MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 303. BRICS MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 304. BRICS MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 305. BRICS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 306. BRICS MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 307. BRICS MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 308. BRICS MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 309. BRICS MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 310. BRICS MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 311. BRICS MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 312. BRICS MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 313. BRICS MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 314. BRICS MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 315. G7 MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 316. G7 MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 317. G7 MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 318. G7 MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 319. G7 MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 320. G7 MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 321. G7 MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 322. G7 MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 323. G7 MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 324. G7 MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 325. G7 MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 326. G7 MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 327. G7 MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 328. G7 MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 329. G7 MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 330. G7 MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 331. NATO MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 332. NATO MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 333. NATO MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 334. NATO MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 335. NATO MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 336. NATO MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 337. NATO MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 338. NATO MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 339. NATO MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 340. NATO MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 341. NATO MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 342. NATO MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 343. NATO MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 344. NATO MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 345. NATO MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 346. NATO MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 347. UNITED STATES MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 348. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 349. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 350. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 351. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 352. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 353. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 354. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 355. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 356. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 357. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 358. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 359. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY DETECTION CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 360. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 361. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 362. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 363. CANADA MOLECULAR METHODS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 364. CANADA MOLECULAR METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 365. CANADA MOLECULAR METHODS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 366. CANADA MOLECULAR METHODS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 367. CANADA MOLECULAR METHODS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 368. CANADA MOLECULAR METHODS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 369. CANADA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 370. CANADA MOLECULAR METHODS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
TABLE 371. CANADA MOLECULAR METHODS MARKET SIZE, BY MICROARRAYS, 2018-2032 (USD MILLION)
TABLE 372. CANADA MOLECULAR METHODS MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 373. CANADA MOLECULAR METHODS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 374.

Companies Mentioned

The companies featured in this Molecular Methods market report include:

Abbott Laboratories
Agilent Technologies Inc.
Becton Dickinson and Company
Bio-Rad Laboratories Inc
bioMérieux SA
Danaher Corporation
DiaSorin S.p.A
Eurofins Scientific SE
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
GenScript Biotech Corporation
Guardant Health Inc
Hologic Inc.
Illumina Inc.
Lonza Group AG
Merck KGaA
Molbio Diagnostics Private Limited
Myriad Genetics Inc
Natera Inc
NeoGenomics Laboratories Inc.
QIAGEN N.V
Revvity Inc
Sartorius AG
Seegene Inc.
SGS SA
Sysmex Corporation
Thermo Fisher Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	195
Published	June 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.79 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.22 Billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global
No. of Companies Mentioned	28

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3211EUR$3,545USD£2,770GBP €3568EUR$3,939USD£3,078GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4858EUR$5,363USD£4,191GBP €5398EUR$5,959USD£4,657GBP

Molecular Methods Market by Product Type, Technology, Automation Level, Detection Chemistry, Application, End User - Global Forecast 2026-2032

Transformative Shifts in the Molecular Methods Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights for Molecular Methods

Key Group Insights Across Strategic Blocs

Key Country Insights for Molecular Methods

Actionable Recommendations for Industry Leaders

Research Methodology for Molecular Methods Insights

Conclusion: Molecular Methods as a Precision Health Foundation

Table of Contents

Companies Mentioned

Table Information

Transformative Shifts in the Molecular Methods Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights for Molecular Methods

Key Group Insights Across Strategic Blocs

Key Country Insights for Molecular Methods

Actionable Recommendations for Industry Leaders

Research Methodology for Molecular Methods Insights

Conclusion: Molecular Methods as a Precision Health Foundation

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032

Automation in the Molecular Diagnostics Market - Global Forecast 2026-2032

Molecular Diagnostics Market Report and Forecast 2025-2034

Molecular Diagnostics in Infectious Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Oncology Molecular Diagnostics - Global Strategic Business Report